📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

A Review of Perspectives on the Use of Randomization in Phase II Oncology Trials. (2019)

First Author: Grayling MJ

Attributed to: Adaptive Clinical Trials funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/jnci/djz126

PubMed Identifier: 31218346

Publication URI: http://europepmc.org/abstract/MED/31218346

Type: Journal Article/Review

Volume: 111

Parent Publication: Journal of the National Cancer Institute

Issue: 12

ISSN: 0027-8874